Menin, a chromatin adaptor which interacts with MLL1/KMT2A and is implicated in the pathogenesis of NPM1-mutated AML, has been studied as a therapeutic target in both myeloid and lymphoid malignancies (182, 183). Here, KMT2A is linked to acute myeloid leukemia.